Nutritional challenges and outcomes after surgery for congenital heart disease

Current Opinion in Cardiology

Volumn 25, Issue 2, 2010, Pages 88-94

  Cabrera, Antonio G ^a   Prodhan, Parthak ^b,c   Bhutta, Adnan T ^b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cardiac surgery; Children; Feeding; Morbidity; Mortality; Nutrition

Indexed keywords

ARGININE; C REACTIVE PROTEIN; GLUTAMINE; INSULIN; MAGNESIUM; PREALBUMIN; VITAMIN D; ZINC;

CALORIC INTAKE; CARBOHYDRATE INTAKE; CHILD; CHYLOTHORAX; CLINICAL PROTOCOL; CONGENITAL HEART DISEASE; CRITICALLY ILL PATIENT; DIET THERAPY; DYSPHAGIA; ENTERIC FEEDING; GLYCEMIC CONTROL; HEART SURGERY; HUMAN; HYPERGLYCEMIA; HYPOPLASTIC LEFT HEART SYNDROME; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; KIDNEY FAILURE; MINERAL INTAKE; MOTOR PERFORMANCE; NUTRITION; OROPHARYNX; PARENTERAL NUTRITION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; SURGICAL PATIENT; TREATMENT OUTCOME; VITAMIN INTAKE; VOCAL CORD DISORDER; WEIGHT GAIN;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHYLOTHORAX; CRITICAL CARE; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; HEART DEFECTS, CONGENITAL; HUMANS; INFLAMMATION; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; POSTOPERATIVE PERIOD; PREALBUMIN; TREATMENT OUTCOME;

EID: 76749141362     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283365490     Document Type: Review

References (71)

1. Kelleher DK, Laussen P, Teixeira-Pinto A, Duggan C. Growth and correlates of nutritional status among infants with hypoplastic left heart syndrome (HLHS) after stage 1 Norwood procedure. Nutrition 2006; 22:237-244.
2. Pollack MM, Ruttimann UE, Wiley JS. Nutritional depletions in critically ill children: associations with physiologic instability and increased quantity of care. JPEN J Parenter Enteral Nutr 1985; 9:309-313.
3. Briassoulis G, Zavras N, Hatzis T. Malnutrition, nutritional indices, and early enteral feeding in critically ill children. Nutrition 2001; 17:548-557.
4. Madhok AB, Ojamaa K, Haridas V, et al. Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol 2006; 27:408-413.
5. Agus MS, Jaksic T. Nutritional support of the critically ill child. Curr Opin Pediatr 2002; 14:470-481.
6. Leite HP, Fisberg M, de Carvalho WB, et al. Serum albumin and clinical outcome in pediatric cardiac surgery. Nutrition 2005; 21:553-558.
7. Fritz HG, Brandes D, Bredle DL, et al. Postoperative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery. Acta Anaesthesiol Scand 2003; 47:1276-1283.
8. Raguso CA, Dupertuis YM, Pichard C. The role of visceral proteins in the nutritional assessment of intensive care unit patients. Curr Opin Clin Nutr Metab Care 2003; 6:211-216.
9. Chwals WJ, Fernandez ME, Jamie AC, et al. Relationship of metabolic indexes to postoperative mortality in surgical infants. J Pediatr Surg 1993; 28:819-822.
10. Lim SH, Lee JS, Chae SH, et al. Prealbumin is not sensitive indicator of nutrition and prognosis in critical ill patients. Yonsei Med J 2005; 46: 21-26.
11. Pinilla JC, Hayes P, Laverty W, et al. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery 1998; 124:799-805; discussion 805-806.
12. Barton JS, Hindmarsh PC, Scrimgeour CM, et al. Energy expenditure in congenital heart disease. Arch Dis Child 1994; 70:5-9.
13. Koletzko B, Goulet O, Hunt J, et al. Parenteral Nutrition Guidelines Working Group; European Society for Clinical Nutrition and Metabolism; European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Society of Paediatric Research (ESPR). 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005; 41 (Suppl 2):S1-S87.
14. Wintergerst KA, Buckingham B, Gandrud L, et al. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006; 118:173-179.
15. Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007; 132:268-278.
16. Yung M, Wilkins B, Norton L, et al. Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med 2008; 9:147.D-152.D.
17. Srinivasan V, Spinella PC, Drott HR, et al. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 2004; 5:329-336.
18. Rossano JW, Taylor MD, Smith EO, et al. Glycemic profile in infants who have undergone the arterial switch operation: hyperglycemia is not associated with adverse events. J Thorac Cardiovasc Surg 2008; 135:739-745.
19. Yates AR, Dyke PC 2nd, Taeed R, et al. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med 2006; 7:351-355.
20. de Ferranti S, Gauvreau K, Hickey PR, et al. Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology 2004; 100:1345-1352.
21. Ballweg JA, Wernovsky G, Ittenbach RF, et al. Hyperglycemia after infant cardiac surgery does not adversely impact neurodevelopmental outcome. Ann Thorac Surg 2007; 84:2052-2058.
22. Polito A, Thiagarajan RR, Laussen PC, et al. Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery. Circulation 2008; 118:2235-2242.
23. Vlasselaers I, Milants L, Desmet P, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 2009; 373:547-556.
24. Agus M. Maintaining normal blood sugar levels in children undergoing heart surgery to reduce the risk of infections and improve recovery (The SPECS Study). http://clinicaltrials.gov/ct2/show/NCT00443599.
25. Kreymann KG, Berger MM, Deutz NE, et al. ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr 2006; 25:210-223.
26. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002; 26 (1 Suppl):1SA-138SA.
27. Willis L, Kaufman J, Wymore E, et al. Enteral feeding in prostaglandindependent neonates: is it a safe practice? J Pediatr 2008; 153:867-869.
28. Schwalbe-Terilli CR, Hartman DH, Nagle ML, et al. Enteral feeding and caloric intake in neonates after cardiac surgery. Am J Crit Care 2009; 18:52-57.
29. Del Castillo SL, McCulley ME, Khemani RG, et al. Reducing the incidence of necrotizing enterocolitis in neonates with hypoplastic left heart syndrome with the introduction of an enteral feed protocol. Pediatr Crit Care Med 2009. [Epub ahead of print]
30. Braudis NJ, Curley MA, Beaupre K, et al. Enteral feeding algorithm for infants with hypoplastic left heart syndrome poststage I palliation. Pediatr Crit Care Med 2009; 10:460-466.
31. Sanchez C, Lopez-Herce J, Carrillo A, et al. Transpyloric enteral feeding in the postoperative of cardiac surgery in children. J Pediatr Surg 2006; 41:1096-1102.
32. Venter M, Rode H, Sive A, et al. Enteral resuscitation and early enteral feeding in children with major burns: effect on McFarlane response to stress. Burns 2007; 33:464-471.
33. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52:1949-1956.
34. Nemerovski CW, Dorsch MP, Simpson RU, et al. Vitamin D and cardiovascular disease. Pharmacotherapy 2009; 29:691-708.
35. Maiya S, Sullivan I, Allgrove J, et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart 2008; 94:581-584.
36. Booth JV, Phillips-Bute B, McCants CB, et al. Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery. Am Heart J 2003; 145:1108-1113.
37. Forlani S, Moscarelli M, Scafuri A, et al. Combination therapy for prevention of atrial fibrillation after coronary artery bypass surgery: a randomized trial of sotalol and magnesium. Card Electrophysiol Rev 2003; 7:168-171.
38. Munoz R, Laussen PC, Palacio G, et al. Whole blood ionized magnesium: agerelated differences in normal values and clinical implications of ionized hypomagnesemia in patients undergoing surgery for congenital cardiac disease. J Thorac Cardiovasc Surg 2000; 119:891-898.
39. Manrique AM, Arroyo M, Lin Y, et al. Magnesium supplementation during cardiopulmonary bypass to prevent junctional ectopic tachycardia after pediatric cardiac surgery: a randomized controlled study. J Thorac Cardiovasc Surg 2010; 139:162-169. A randomized controlled trial in children showed benefit from a one-time dose, that is, 50 mg/kg intraoperative supplementation of magnesium sulfate reducing the incidence of junctional ectopic tachycardia on arrival at the cardiac ICU.
40. Cvijanovich NZ, King JC, Flori HR, et al. Zinc homeostasis in pediatric critical illness. Pediatr Crit Care Med 2009; 10:29-34.
41. Aneja RK. Zinc: jack of all trades, master of none¡ Pediatr Crit Care Med 2009; 10:129-131.
42. Heyland DK, Jones N, Cvijanovich NZ, et al. Zinc supplementation in critically ill patients: a key pharmaconutrient? JPEN J Parenter Enteral Nutr 2008; 32:509-519.
43. Shi SS, Shi CC, Zhao ZY, et al. Effect of open heart surgery with cardiopulmonary bypass on peripheral blood lymphocyte apoptosis in children. Pediatr Cardiol 2009; 30:153-159.
44. Cabrera AG, Dyamenahalli U, Gossett J, et al. Preoperative lymphopenia is a predictor of postoperative adverse outcomes in children with congenital heart disease. J Thorac Cardiovasc Surg 2009; 138:1172-1179.
45. Felmet KA, Hall MW, Clark RS, et al. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 2005; 174:3765-3772.
46. Wischmeyer PE. Glutamine: mode of action in critical illness. Crit Care Med 2007; 35 (9 Suppl):S541-S544.
47. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev 1990; 48:297-309.
48. Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286:944-953.
49. Novak F, Heyland DK, Avenell A, et al. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002; 30:2022-2029.
50. Tubman TR, Thompson SW, McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2008:CD001457.
51. Carcillo J, Holubkov R, Dean JM, et al., Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network. Rationale and design of the pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. JPEN J Parenter Enteral Nutr 2009; 33:368-374.
52. Jones NE, Heyland DK. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol 2008; 24:215-222.
53. Huang Y, Shao XM, Neu J. Immunonutrients and neonates. Eur J Pediatr 2003; 162:122-128.
54. Panthongviriyakul C, Bines JE. Post-operative chylothorax in children: an evidence based management algorithm. J Paediatr Child Health 2008; 44: 716-721.
55. Chan SY, Lau W, Wong WH, et al. Chylothorax in children after congenital heart surgery. Ann Thorac Surg 2006; 82:1650-1656.
56. Lim KA, Kim SH, Huh J, et al. Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease. J Korean Med Sci 2005; 20:947-951.
57. BÜttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest 1999; 116:682-687.
58. Winkler MF. Nutrition management of the patient with chylous fistula. Support Line 2003; 25:8-18.
59. Buttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest 1999; 116:682-687.
60. Cormack BE, Wilson NJ, Finucane K, et al. Use of monogen for pediatric postoperative chylothorax. Ann Thorac Surg 2004; 77:301-305.
61. Nath DS, Savla J, Khemani RG, et al. Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery. Ann Thorac Surg 2009; 88:246-251.
62. Li J, Zhang G, Herridge J, et al. Energy expenditure and caloric and protein intake in infants following the Norwood procedure. Pediatr Crit Care Med 2008; 9:55-61.
63. Druml W. Nutritional management of acute renal failure. J Ren Nutr 2005; 15:63-70.
64. Wooley JA, Btaiche IF, Good KL. Metabolic and nutritional aspects of acute renal failure in critically ill patients requiring continuous renal replacement therapy. Nutr Clin Pract 2005; 20:176-191.
65. Khariwala SS, Lee WT, Koltai PJ. Laryngotracheal consequences of pediatric cardiac surgery. Arch Otolaryngol Head Neck Surg 2005; 131:336-339.
66. Zbar RI, Chen AH, Behrendt DM, et al. Incidence of vocal fold paralysis in infants undergoing ligation of patent ductus arteriosus. Ann Thorac Surg 1996; 61:814-816.
67. Zbar RI, Smith RJ. Vocal fold paralysis in infants twelve months of age and younger. Otolaryngol Head Neck Surg 1996; 114:18-21.
68. Skinner ML, Halstead LA, Rubinstein CS, et al. Laryngopharyngeal dysfunction after the Norwood procedure. J Thorac Cardiovasc Surg 2005; 130:1293-1301.
69. Sachdeva R, Hussain E, Moss MM, et al. Vocal cord dysfunction and feeding difficulties after pediatric cardiovascular surgery. J Pediatr 2007; 151:312-315; 315.e1-2
70. Ghanayem NS, Hoffman GM, Mussatto KA, et al. Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg 2003; 126:1367-1377.
71. Srinivasan C, Sachdeva R, Morrow WR, et al. Standardized management improves outcomes after the Norwood procedure. Congenit Heart Dis 2009; 4:329-337.